Skip to main content
Log in

Survival benefits of metabolic syndrome among older men aged 75 years and over in Taiwan

  • Published:
The journal of nutrition, health & aging

Abstract

Background

Metabolic syndrome (MetS) was common in the elderly, but its prognostic significance in older old population remained unclear. The main purpose of this study was to evaluate the survival impact of MetS among older men aged 75 and over in Taiwan.

Methods

From 2008, residents aged 75 years and older of Banciao Veterans Home were invited for study and were followed for 3 years. All participants received history taking, physical examinations, and laboratory tests. Mortality was determined by Veteran Affairs Death Registry, which was linked to the National Death Registry.

Results

Overall, 680 men (mean age: 82.5±47 years) were enrolled for study and the prevalence of MetS was 31.6%. During the follow-up period, 140 (20.6%) participants died, and the causes of death included infectious diseases (62, 9.1%), cardiovascular disease (37, 5.4%), cancer (20, 2.9%), and others (21, 3.1%). MetS subjects had a significantly higher prevalence of hypertension, diabetes mellitus, and having higher body mass index, waist circumferences, systolic blood pressure, fasting blood glucose, serum triglyceride and lower HDL-C level than non-MetS subjects. However, MetS subjects were less likely to die during study period (16.3% vs. 22.6%, P=0.059). Multivariate logistic regression showed that older age (OR: 1.04, 95% C.I.: 1.00–1.08, P=0.04), diabetes mellitus (OR: 2.10, 95% CI: 1.34–3.30, P=0.001) were independent risk factors for mortality; and serum total cholesterol and triglyceride were protective factors (OR: 0.99, 95% CI: 0.99–1.00, P=0.037 for cholesterol; OR: 0.99, 95% CI: 0.99–1.00, P=0.013 for triglyceride). Adjusted for age, diabetes mellitus, serum levels of total cholesterol, and triglyceride, MetS played a potential trend of survival benefits among study subjects (HR: 0.71, 95% CI: 045–1.12, P=0.144).

Conclusions

The prevalence of MetS among men aged 75 years and over was 31.6%, and the 3-year mortality rate was 20.6%. Older age, diabetes mellitus, lower serum cholesterol and lower serum triglyceride were independent risk factors for mortality. Further investigation is needed to clarify the prognostic impact of MetS in older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kylin E. Studien ueber das Hypertonie-Hyperglyka “mie-Hypemrika” miesyndrom. Zentralblatt fuer Innere Medizin 1923;44:105–127.

    Google Scholar 

  2. Zavaroni I, Bonora E, Pagliara M, Dall’Aglio E, Luchetti L, Buonnano G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, et al.: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989;320:502–506.

    Article  Google Scholar 

  3. Ferrannini E, Haffner SM, Mitchell BD, Stem MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416–422.

    Article  PubMed  CAS  Google Scholar 

  4. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715–722.

    Article  PubMed  CAS  Google Scholar 

  5. Kahn R, Ferrannini E, Buse J, Stern M: The metabolic syndrome: Time for a critical appraisal. Diabetes Care 2005;28:2289–2304.

    Article  PubMed  Google Scholar 

  6. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 2004;33:333–350.

    Article  PubMed  Google Scholar 

  7. Cameron AJ, Shaw JE, Zimmet, PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351–375.

    Article  PubMed  Google Scholar 

  8. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–689.

    Article  PubMed  CAS  Google Scholar 

  9. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28:385–390.

    Article  PubMed  Google Scholar 

  10. Franco OH, Massaro JM, Civil J, Cobain MR, O’Malley B, D’Agostino RB, Sr. Trajectories of entering the metabolic syndrome: the Framingham heart study. Circulation 2009;120:1943–1950.

    Article  PubMed  Google Scholar 

  11. Khang YH, Cho SI, Kim HR. Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. Atherosclerosis 2010;213:579–585.

    Article  PubMed  CAS  Google Scholar 

  12. Curtis LH, Anstrom KJ, Hammill BG, Gottdiener JS, Bethel MA, Schulman KA. Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study. Diabetes Care 2007;30:2553–2558.

    Article  PubMed  Google Scholar 

  13. Akbaraly TN, Kivimaki M, Ancelin ML, Barberger-Gateau P, Mura T, Tzourio C, et al. Metabolic Syndrome, Its Components, and Mortality in the Elderly. J Clin Endocrinol Metab 2010; 95:E327–E332.

    Article  PubMed  Google Scholar 

  14. Hillier TA, Rizzo JH, Pedula KL, Cauley JA, Schwartz AV, Ensrud KE, Browner WS. Increased mortality associated with the metabolic syndrome in older women with diabetes. Diabetes Care 2005;28:2258–2260.

    Article  PubMed  Google Scholar 

  15. Otiniano ME, Du XL, Maldonado MR, Ray L, Markides K. Effect of metabolic syndrome on heart attack and mortality in Mexican-American elderly persons: findings of 7-year follow-up from the Hispanic established population for the epidemiological study of the elderly. J Gerontol A Biol Sci. Med Sci 2005;60:466–470.

    Article  PubMed  Google Scholar 

  16. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007;28:857–864.

    Article  PubMed  Google Scholar 

  17. Wen CJ, Lee YS, Lin WY, Huang HL, Yao CA, Sung PK, Huang KC. The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly. Eur J Clin Invest 2008;38:469–475.

    Article  PubMed  CAS  Google Scholar 

  18. Mozaffarian D, Kamineni A, Prineas RJ, Siscovick DS. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2008;168:969–978.

    Article  PubMed  Google Scholar 

  19. Akbaraly TN, Kivimaki M, Ancelin ML, Barberger-Gateau P, Mura T, Tzourio C, Touchon J, Ritchie K, Berr C. Metabolic syndrome, its components, and mortality in the elderly. J Clin Endocrinol Metab 2010;95:E327–E332.

    Article  PubMed  Google Scholar 

  20. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE, Satterfield S, Newman AB, Goodpaster B, Bauer DC, Holvoet P, Harris TB, de Rekeneire N, Rubin S, Ding J, Kritchevsky SB. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006;47:1595–1602.

    Article  PubMed  Google Scholar 

  21. Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, Montesi F, Bolondi L, Patterson C. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care 2006;29:2471–2476.

    Article  PubMed  CAS  Google Scholar 

  22. Vischer UM, Safar ME, Safar H, Iaria P, Le Dudal K, Henry O, Herrmann FR, Ducimetiere P, Blacher J. Cardiometabolic determinants of mortality in a geriatric population: is there a “reverse metabolic syndrome”? Diabetes Metab 2009;35:108–114.

    Article  PubMed  CAS  Google Scholar 

  23. Lin JW, Caffrey JL, Chang MH, Lin YS. Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality-cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2010; 95:4258–4267.

    Article  PubMed  CAS  Google Scholar 

  24. From the Centers for Disease Control and Prevention. Public health and aging: trends in aging-United States and worldwide. JAMA 2003;289:1371–1373.

    Article  Google Scholar 

  25. Chen LK, Peng LN, Lin MH, Lai HY, Hwang SJ, Lan CF. Predicting mortality of older adults in long-term care facilities: comorbidity or care problems? J Am Med Dir Assoc 2010;11:567–571.

    Article  PubMed  Google Scholar 

  26. Chen YM, Hwang SJ, Chen LK, Chen DY, Lan CF. Urinary incontinence among institutionalized oldest old Chinese men in Taiwan. Neurourol Urodyn 2009;28:335–338.

    Article  PubMed  Google Scholar 

  27. Chen YM, Hwang SJ, Chen LK, Chen DY, Lan CF. Risk factors for falls among elderly men in a veteran home. J Chin Med Assoc 2008;71:180–185.

    Article  PubMed  Google Scholar 

  28. Chen LK, Peng LN, Lin MH, Lai HY, Hwang SJ, Chiou ST. Predicting new onset diabetes mellitus in older Taiwanese: metabolic syndrome or impaired fasting glucose? J Atheroslcer Thromb 2009;16:627–632.

    Article  Google Scholar 

  29. Thomas F, Pannier B, Benetos A, Vischer UM. The impact of the metabolic syndrome — but not of hypertension — on all-cause mortality disappears in the elderly. J Hypertens 2011 (in press)

  30. Salminen M, Kuoppamaki M, Vahlberg T, Raiha I, Irjala K, Kivela SL. The metabolic syndrome defined by modified International Diabetes Federation criteria and mortality: a 9-year follow-up of the aged in Finland. Diabetes Metab 2010; 36:437–442.

    Article  PubMed  CAS  Google Scholar 

  31. Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc 2005;53, 219–226.

    Article  PubMed  Google Scholar 

  32. Nago N, Ishikawa S, Goto T, Kayaba K. Low Cholesterol is Associated With Mortality From Stroke, Heart Disease, and Cancer: The Jichi Medical School Cohort Study. J Epidemiol 2011;21:67–74.

    Article  PubMed  Google Scholar 

  33. Tuikkala P, Hartikainen S, Korhonen MJ, Lavikainen P, Kettunen R, Sulkava R, Enlund H. Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up. Scand J Prim Health Care 2010;28:121–127.

    Article  PubMed  Google Scholar 

  34. Stengard JH, Tuomilehto J, Pekkanen J, Kivinen P, Kaarsalo E, Nissinen A, Karvonen MJ. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study. Diabetologia 1992;35:760–765.

    PubMed  CAS  Google Scholar 

  35. Bertoni AG, Kirk JK, Goff DC, Jr, Wagenknecht LE. Excess mortality related to diabetes mellitus in elderly Medicare beneficiaries. Ann Epidemiol 2004;14:362–367.

    Article  PubMed  Google Scholar 

  36. Chen LK, Chen YM, Lin MH, Peng LN, Hwang SJ. Care of elderly patients with diabetes mellitus: a focus on frailty. Ageing Res Rev 2010;9(Suppl 1): S18–S22.

    Article  PubMed  Google Scholar 

  37. Chen CY. Meeting the challenges of eldercare in Taiwan’s aging society. J Clin Gerontol Geriatr 2010;1:2–4.

    Article  CAS  Google Scholar 

  38. Stenholm S, Koster A, Alley DE, Houston DK, Kanaya A, Lee JS, Newman AB, Satterfield S, Simonsick EM, Visser M, Harris TB, Ferrucci L. Joint association of obesity and metabolic syndrome with incident mobility limitation in older men and women-results from the Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci 2010;65:84–92.

    Article  PubMed  Google Scholar 

  39. Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L. Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 2009;17:889–898.

    Article  PubMed  Google Scholar 

  40. Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, Fried LP. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 2007; 167:635–641.

    Article  PubMed  Google Scholar 

  41. Hassenstab JJ, Sweat V, Braehl H, Convit A. Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord 2010;29:356–362.

    Article  PubMed  Google Scholar 

  42. Abbatecola, AM, Paolisso G. Is there a relationship between insulin resistance and frailty syndrome? Curr Pharm Des 2008; 14:405–410.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liang-Kung Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiang, P.H., Liu, C.L., Lin, M.H. et al. Survival benefits of metabolic syndrome among older men aged 75 years and over in Taiwan. J Nutr Health Aging 16, 520–524 (2012). https://doi.org/10.1007/s12603-011-0344-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-011-0344-6

Key words

Navigation